BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 12499799)

  • 21. The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
    Gotto J; Webster GJ; Brown D; Jenkins J; Dusheiko GM; Bertoletti A
    J Viral Hepat; 2006 Jun; 13(6):415-25. PubMed ID: 16842445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B.
    Lin CY; Tsai MC; Huang CT; Hsu CW; Tseng SC; Tsai IF; Chen YC; Yeh CT; Sheen IS; Chien RN
    J Viral Hepat; 2007 Jul; 14(7):503-11. PubMed ID: 17576392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
    Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
    J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
    Sprengers D; van der Molen RG; Kusters JG; Hansen B; Niesters HG; Schalm SW; Janssen HL
    J Med Virol; 2006 May; 78(5):561-8. PubMed ID: 16555293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
    Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL
    J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection.
    Li X; Chen Y; Ma Z; Ye B; Wu W; Li L
    Cell Immunol; 2010; 264(1):42-6. PubMed ID: 20483408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
    Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
    Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
    Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of kurarinol on peripheral blood CTL surface PD-1 expression of patients with chronic hepatitis B].
    Zhu YF; Gu XB; Yang XJ; Hua Z; Lu ZH; Zang B; Wu HY; Jiang YM; Chen HK; Pei H; Xu YQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):446-9. PubMed ID: 23627026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
    Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
    Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of circulating HBV specific CD8+ T cells in hepatitis B patients by flow cytometry and its clinical significance].
    Yao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):476-8. PubMed ID: 21604582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection.
    Boni C; Amadei B; Urbani S; Fisicaro P; Zerbini A; Mori C; Missale G; Bertoni R; Azzurri A; Del Prete G; Ferrari C
    Hepatology; 2004 Aug; 40(2):289-99. PubMed ID: 15368433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.